Terveystalo Logo
FI4000252127
A2H5F4
TTALO.HE

Terveystalo

Loading quotes...

Forecast

There is no analyst data available for this company.


  • Terveystalo Q3: revenue falls, margins and cash flow improve – stock plunges

    Terveystalo reported a 5.2% decline in revenue for Q3 2025 to €280.4m, while adjusted EBIT remained almost stable at €26.8m and the adjusted EBIT margin rose to 9.5%. Earnings per share climbed 9.7% to €0.13 and operating cash flow increased 32% to €54.5m. Causes of the revenue decline include reduced outsourcing contracts, fewer occupational health services and lower sickness rates; the business in Sweden remains loss-making but is improving. Management confirmed the full-year guidance for adjusted EBIT of €155–165m; the share fell 8.25% to €9.23 after the release. » More on de.investing.com


  • Terveystalo share falls after 5% revenue decline in third quarter

    Terveystalo reported a 5% revenue decline in Q3 2025 but maintained its adjusted EBIT guidance of €155–165m. The adjusted EBIT margin and operating cash flow improved, while the leverage ratio stood at 2.1. The stock reacted negatively, falling 8.15% in pre-market trading to $9.24. The company continues to invest in digital health services and expects growth in connected employees through 2026. » More on de.investing.com


  • Terveystalo reports record profitability in Q2 2025, shares fall despite strong EBIT

    Terveystalo achieved record profitability in the second quarter of 2025 with EBIT of €36.7 million and a margin of 11.4%, but saw a slight decline in revenue compared to the previous year. The stock fell 7.35% in pre-market trading as investors expressed concerns about the revenue drop and weakness in the occupational health segment, despite strong profitability. The company maintains its full-year EBIT guidance and continues to focus on digital transformation and technological innovation. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics
In 2026, Terveystalo has already paid €0.64 in dividends. The last payout was in October.

Financials

In the last quarter, Terveystalo had revenue of €257.32M and net profit of €5.38M
(EUR) September 2026
YoY
Revenue 257.32M 8.40%
Gross profit 45.02M 17.69%
Net profit 5.38M 66.83%
EBITDA 41.01M 15.60%

Fundamentals

Metric Value
Market capitalization
€812.03M
Number of shares
126.81M
52-week high/low
€11.53 - €6.40
Dividend yield
10.27%
Dividends TTM
€0.64
Beta
0.37
P/E ratio
13.74
PEG ratio
-0.37
P/B ratio
1.47
P/S ratio
0.66

Company profile

Terveystalo Oyj provides occupational healthcare services in Finland. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; and outsourcing services, staffing services, child welfare services, oral health, laboratory, imaging, wellbeing, day surgery, healthcare outsourcing, healthcare staffing, and primary and specialty care services. It also provides a suite of digital healthcare services; and clinical research services. The company serves private individuals, companies and communities, insurance companies, and public sector customers. It operates 360 clinics, which include 18 hospital units and 38 dental clinics; and 73 Rela hierojat massage therapy units. The company was founded in 2001 and is based in Helsinki, Finland.

Name
Terveystalo
CEO
Ville Iho
Headquarters Helsinki, uu
Finland
Website
IPO
10/11/2017
Employees 8,356

Ticker symbols

Exchange Symbol
Hel
TTALO.HE
Pnk
TTALF
Helsinki
TTALO.HE
Frankfurt
4TS.F
Düsseldorf
4TS.DU
London
0RV1.L
München
4TS.MU
🍪

Parqet  uses cookies. Learn more